In line with the observations in the prostate tissues, CMG2 was expressed at relatively high levels in the four prostate cancer cell lines (PC-3, DU-145, CA-HPV-10 and LNCaP) compared with its expression in the three immortalised prostate epithelial cell lines (PZHPV-7, PNT1A and PNT2C2). This evidence concerns the gene ANTXR2 and prostate carcinoma.